Your browser doesn't support javascript.
loading
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.
Shimelis, Hermela; Mesman, Romy L S; Von Nicolai, Catharina; Ehlen, Asa; Guidugli, Lucia; Martin, Charlotte; Calléja, Fabienne M G R; Meeks, Huong; Hallberg, Emily; Hinton, Jamie; Lilyquist, Jenna; Hu, Chunling; Aalfs, Cora M; Aittomäki, Kristiina; Andrulis, Irene; Anton-Culver, Hoda; Arndt, Volker; Beckmann, Matthias W; Benitez, Javier; Bogdanova, Natalia V; Bojesen, Stig E; Bolla, Manjeet K; Borresen-Dale, Anne-Lise; Brauch, Hiltrud; Brennan, Paul; Brenner, Hermann; Broeks, Annegien; Brouwers, Barbara; Brüning, Thomas; Burwinkel, Barbara; Chang-Claude, Jenny; Chenevix-Trench, Georgia; Cheng, Ching-Yu; Choi, Ji-Yeob; Collée, J Margriet; Cox, Angela; Cross, Simon S; Czene, Kamila; Darabi, Hatef; Dennis, Joe; Dörk, Thilo; Dos-Santos-Silva, Isabel; Dunning, Alison M; Fasching, Peter A; Figueroa, Jonine; Flyger, Henrik; García-Closas, Montserrat; Giles, Graham G; Glendon, Gord; Guénel, Pascal.
Afiliación
  • Shimelis H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Mesman RLS; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Von Nicolai C; Genotoxic Stress and Cancer, Institut Curie, Orsay, France.
  • Ehlen A; Genotoxic Stress and Cancer, Institut Curie, Orsay, France.
  • Guidugli L; Department of Human Genetics, University of Chicago, Chicago, Illinois.
  • Martin C; Research Center, Institute Curie, Orsay, France.
  • Calléja FMGR; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Meeks H; Cancer Control and Population Sciences, University of Utah, Salt Lake City, Utah.
  • Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Hinton J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Lilyquist J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Hu C; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Aalfs CM; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Andrulis I; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
  • Anton-Culver H; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Arndt V; Department of Epidemiology, University of California Irvine, Irvine, California.
  • Beckmann MW; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Benitez J; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Bogdanova NV; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
  • Bojesen SE; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
  • Bolla MK; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Borresen-Dale AL; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Brauch H; Copenhagen General Population Study, Herlevand Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brennan P; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brenner H; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Broeks A; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Brouwers B; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Brüning T; K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Burwinkel B; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Chang-Claude J; University of Tübingen, Tübingen, Germany.
  • Chenevix-Trench G; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cheng CY; International Agency for Research on Cancer, Lyon, France.
  • Choi JY; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Collée JM; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cox A; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Cross SS; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Czene K; Laboratory of Experimental Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Darabi H; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Dennis J; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
  • Dörk T; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Dos-Santos-Silva I; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dunning AM; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fasching PA; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Flyger H; Singapore Eye Research Institute, National University of Singapore, Singapore, Singapore.
  • García-Closas M; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Giles GG; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Glendon G; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Guénel P; Sheffield Cancer Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
Cancer Res ; 77(11): 2789-2799, 2017 06 01.
Article en En | MEDLINE | ID: mdl-28283652
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA2 Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Aged / Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA2 Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Aged / Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2017 Tipo del documento: Article